The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys

Louisa Degenhardt*, Chrianna Bharat, Meyer D. Glantz, Nancy A. Sampson, Kate Scott, Carmen C.W. Lim, Sergio Aguilar-Gaxiola, Ali Al-Hamzawi, Jordi Alonso, Laura H. Andrade, Evelyn J. Bromet, Ronny Bruffaerts, Brendan Bunting, Giovanni de Girolamo, Oye Gureje, Josep Maria Haro, Meredith G. Harris, Yanling He, Peter de Jonge, Elie G. KaramGeorges E. Karam, Andrzej Kiejna, Sing Lee, Jean Pierre Lepine, Daphna Levinson, Victor Makanjuola, Maria Elena Medina-Mora, Zeina Mneimneh, Fernando Navarro-Mateu, José Posada-Villa, Dan J. Stein, Hisateru Tachimori, Yolanda Torres, Zahari Zarkov, Somnath Chatterji, Ronald C. Kessler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

Background: Illicit drug use and associated disease burden are estimated to have increased over the past few decades, but large gaps remain in our knowledge of the extent of use of these drugs, and especially the extent of problem or dependent use, hampering confident cross-national comparisons. The World Mental Health (WMH) Surveys Initiative involves a standardised method for assessing mental and substance use disorders via structured diagnostic interviews in representative community samples of adults. We conducted cross-national comparisons of the prevalence and correlates of drug use disorders (DUDs) in countries of varied economic, social and cultural nature. Methods and findings: DSM-IV DUDs were assessed in 27 WMH surveys in 25 countries. Across surveys, the prevalence of lifetime DUD was 3.5%, 0.7% in the past year. Lifetime DUD prevalence increased with country income: 0.9% in low/lower-middle income countries, 2.5% in upper-middle income countries, 4.8% in high-income countries. Significant differences in 12-month prevalence of DUDs were found across country in income groups in the entire cohort, but not when limited to users. DUDs were more common among men than women and younger than older respondents. Among those with a DUD and at least one other mental disorder, onset of the DUD was usually preceded by the ‘other’ mental disorder. Conclusions: Substantial cross-national differences in DUD prevalence were found, reflecting myriad social, environmental, legal and other influences. Nonetheless, patterns of course and correlates of DUDs were strikingly consistent. These findings provide foundational data on country-level comparisons of DUDs.

Original languageEnglish
Pages (from-to)103-112
Number of pages10
JournalInternational Journal of Drug Policy
Volume71
DOIs
StatePublished - Sep 2019
Externally publishedYes

Funding

FundersFunder number
Alcohol Advisory Council
Argentinian Ministry of Health
EEA Financial Mechanism
Federal Ministry of Health, Abuja, Nigeria
INPRFMDIES4280
Iceland
Iraq Mental Health Survey
Israel National Health Survey
Israel National Institute for Health Policy and Health Services Research
Lebanese Evaluation of the Burden of Ailments and Needs Of the Nation
Liechtenstein and Norway
Mexican National Comorbidity Survey
Ministry of Social Protection
National Center for Public Health Protection
New Zealand Mental Health Survey
Nigerian Survey of Mental Health and Wellbeing
Norwegian Financial Mechanism
Servicio Murciano de Salud and Consejería de Sanidad y Política Social
South African Department of Health
São Paulo Megacity Mental Health Survey
UNDG
United Nations Development Group Iraq Trust Fund
National Institutes of Health
National Institute of Mental HealthR01MH069864, U01-MH60220, R01-MH059575
National Institute on Drug Abuse
Substance Abuse and Mental Health Services Administration
Fogarty International CenterR03 TW006481-01
Robert Wood Johnson Foundation044708
John D. and Catherine T. MacArthur Foundation
John W. Alden Trust
GlaxoSmithKline
World Health Organization
University of Michigan
Pfizer Foundation
Pan American Health Organization
European CommissionQLG5-1999-01042, SANCO 2004123, EAHC 20081308
National Health and Medical Research Council1081984
Department of Health and Ageing, Australian Government
Ministry of Health, New Zealand
Health Research Council of New Zealand
Public Health Agency
Fundação de Amparo à Pesquisa do Estado de São Paulo03/00204-3
Consejo Nacional de Ciencia y TecnologíaCONACyT-G30544- H
National Insurance Institute of IsraelH25-SEISHIN-IPPAN-006, H16-KOKORO-013, H14-TOKUBETSU-026, H13-SHOGAI-023
Ministerio de Salud de la Nación
Ministry of Health, Labour and Welfare
Ministry of Public Health
Instituto de Salud Carlos IIIFIS 00/0028
Ministerio de Ciencia y TecnologíaSAF 2000-158-CE
NSW Ministry of Health
Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
Fundación para la Formación e Investigación Sanitarias de la Región de MurciaRO1-MH61905
Regione Piemonte
Departament de Salut, Generalitat de CatalunyaRETICS RD06/0011 REM-TAP, CB06/02/0046
Ministerio de SaludPL 0256

    Keywords

    • Abuse
    • Dependence
    • Drugs
    • Epidemiology
    • World Mental Health Surveys

    Fingerprint

    Dive into the research topics of 'The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys'. Together they form a unique fingerprint.

    Cite this